What is Recursion Pharmaceuticals?
Recursion Pharmaceuticals is a ai-enabled drug discovery company company serving enterprise, commercial, consumer, healthcare, financial, real estate, or regulated-market customers.
- Category
- AI-enabled drug discovery company
- Headquarters
- Salt Lake City, United States
- Founded
- See official company history
- Employees
- See latest annual report and company filings
- Total funding
- Public company
- Status
- Public company; Nasdaq: RXRX
What is Recursion Pharmaceuticals?
Recursion Pharmaceuticals is a ai-enabled drug discovery company company headquartered in Salt Lake City, United States. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
Recursion Pharmaceuticals is a ai-enabled drug discovery company company headquartered in Salt Lake City, United States. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
For sellers, Recursion Pharmaceuticals should be mapped as a scaled public-company account. The best timing signals are earnings commentary, capital spending, hiring clusters, product launches, acquisitions, facility investments, and leadership changes.
What does Recursion Pharmaceuticals offer?
Recursion Pharmaceuticals's profile centers on AI drug discovery, Biology maps, Clinical pipeline, Data platform.
- AI drug discovery· AI-enabled drug discovery company
- Biology maps· AI-enabled drug discovery company
- Clinical pipeline· AI-enabled drug discovery company
- Data platform· AI-enabled drug discovery company
- Automation· AI-enabled drug discovery company
- Partnered programs· AI-enabled drug discovery company
How does Recursion Pharmaceuticals make money?
Recursion Pharmaceuticals makes money through commercial activity tied to ai-enabled drug discovery company.
Recursion Pharmaceuticals monetizes through the model common to ai-enabled drug discovery company: product sales, recurring services, contracts, leases, subscriptions, transaction volume, servicing, investment management, or usage depending on the operating unit.
Sales angles should connect to measurable priorities such as margin, growth, occupancy, compliance, retention, automation, risk reduction, data quality, customer experience, or field productivity.
Who leads Recursion Pharmaceuticals?
Recursion Pharmaceuticals's named executives should be verified on the official leadership or investor-relations page before outreach.
- Recursion Pharmaceuticals executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- Recursion Pharmaceuticals finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, capital allocation, and budget discipline.
- Recursion Pharmaceuticals operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operating-improvement purchases.
How do you contact Recursion Pharmaceuticals's leadership?
Recursion Pharmaceuticals should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.
contact via https://www.recursion.com- Recursion Pharmaceuticals investor relationsInvestor relations / corporate contactcontact via https://www.recursion.com
- Recursion Pharmaceuticals sales or partnershipsCommercial contact routecontact via https://www.recursion.com
- Recursion Pharmaceuticals media relationsMedia or communications contact routecontact via https://www.recursion.com
How is Recursion Pharmaceuticals funded?
Recursion Pharmaceuticals's current status is Public company; Nasdaq: RXRX.
Recursion Pharmaceuticals's capital profile is best understood through its current public-company status: Public company; Nasdaq: RXRX. For public companies, financing and budget signals are usually found in annual reports, quarterly results, debt disclosures, buybacks, acquisitions, capital expenditure plans, and management commentary rather than venture funding rounds.
Before outreach, verify the latest status on the company's investor-relations page and current exchange filings.
How did Recursion Pharmaceuticals get here?
Recursion Pharmaceuticals's history should be read through founding, scale-up, public-market ownership, and current product or market focus.
- FoundingRecursion Pharmaceuticals is foundedThe company begins building in ai-enabled drug discovery company.
- Scale-upCommercial footprint expandsRecursion Pharmaceuticals broadens its product, customer, distribution, or geographic reach.
- Public marketsPublic company; Nasdaq: RXRXPublic-company ownership shapes reporting, procurement, and operating priorities.
- 2025Scaled operating profileThe company operates with specialized teams and repeatable buying centers.
- June 2026Current profile refreshedProfile generated from official domain, public-company status, and source references.
Who are Recursion Pharmaceuticals's competitors?
Recursion Pharmaceuticals competes with larger incumbents and focused specialists in ai-enabled drug discovery company.
Recursion Pharmaceuticals — frequently asked questions
